102 related articles for article (PubMed ID: 3009726)
1. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.
Holmes EC; Gail M
J Clin Oncol; 1986 May; 4(5):710-5. PubMed ID: 3009726
[TBL] [Abstract][Full Text] [Related]
2. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large cell undifferentiated carcinoma.
Holmes EC
Chest; 1994 Dec; 106(6 Suppl):293S-296S. PubMed ID: 7988247
[TBL] [Abstract][Full Text] [Related]
3. A randomized comparison of the effects of adjuvant therapy on resected stages II and III non-small cell carcinoma of the lung. The Lung Cancel Study Group.
Holmes EC; Hill LD; Gail M
Ann Surg; 1985 Sep; 202(3):335-41. PubMed ID: 3899029
[TBL] [Abstract][Full Text] [Related]
4. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y
Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515
[TBL] [Abstract][Full Text] [Related]
5. The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group.
J Clin Oncol; 1988 Jan; 6(1):9-17. PubMed ID: 2891798
[TBL] [Abstract][Full Text] [Related]
6. Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a Phase III cancer and Leukemia Group B Study.
Maurer LH; Pajak T; Eaton W; Comis R; Chahinian P; Faulkner C; Silberfarb PM; Henderson E; Rege VB; Baldwin PE
J Clin Oncol; 1985 Jul; 3(7):969-76. PubMed ID: 2991478
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study.
Shepherd FA; Ginsberg RJ; Patterson GA; Evans WK; Feld R
J Thorac Cardiovasc Surg; 1989 Feb; 97(2):177-86. PubMed ID: 2536868
[TBL] [Abstract][Full Text] [Related]
8. A phase 3 randomized trial of immediate combination chemotherapy vs delayed combination chemotherapy in patients with completely resected stage II and III non-small cell carcinoma of the lung.
Figlin RA; Piantodosi S
Chest; 1994 Dec; 106(6 Suppl):310S-312S. PubMed ID: 7988251
[TBL] [Abstract][Full Text] [Related]
9. The importance of surgical and multimodality treatment for small cell bronchial carcinoma.
Karrer K; Shields TW; Denck H; Hrabar B; Vogt-Moykopf I; Salzer GM
J Thorac Cardiovasc Surg; 1989 Feb; 97(2):168-76. PubMed ID: 2536867
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer. An LCSG Trial.
Feld R; Rubinstein L; Thomas PA
Chest; 1994 Dec; 106(6 Suppl):307S-309S. PubMed ID: 7988250
[TBL] [Abstract][Full Text] [Related]
12. [A randomized comparison of radiotherapy with CAP and CVP in non-small cell lung cancer].
Yoneda S; Homma T; Yoshida S; Noguchi Y; Fukuda Y; Nakata M; Sakura M
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2870-1. PubMed ID: 3019254
[No Abstract] [Full Text] [Related]
13. A retrospective analysis of patients receiving surgery after chemotherapy for small cell lung cancer.
Yamada K; Saijo N; Kojima A; Ohe Y; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Goya T; Kondou H
Jpn J Clin Oncol; 1991 Feb; 21(1):39-45. PubMed ID: 1648633
[TBL] [Abstract][Full Text] [Related]
14. Long-term evaluation of intrapleural bacillus Calmette-Guerin with or without adjuvant chemotherapy in completely resected stages II and III non-small-cell lung cancer.
Macchiarini P; Hardin M; Angeletti CA
Am J Clin Oncol; 1991 Aug; 14(4):291-7. PubMed ID: 1650528
[TBL] [Abstract][Full Text] [Related]
15. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
17. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of postoperative immunochemotherapy in lung cancer].
Ikeda T; Sakai T; Suito T; Kosaki G
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1044-9. PubMed ID: 3008669
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
